Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03192358 · ClinicalTrials.gov registry record
Physiological Flow of Liquids Used in Dysphagia Management (Neuro)
A clinical trial, sponsored by University Health Network, Toronto.
- Completed
- Registry status
- 40
- Enrollment target
NCT03192358 is a clinical trial that has completed, run by University Health Network, Toronto. The registered enrollment target is 40 participants.
The verdict
NCT03192358 has completed, sponsored by University Health Network, Toronto.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
For individuals with neurodegenerative conditions, such as Amyotrophic Lateral Sclerosis and Parkinson disease, swallowing impairment (i.e., dysphagia) is a common and serious symptom. Dysphagia places the affected individual at risk for secondary health consequences, including malnutrition and aspiration pneumonia, and negatively affects quality of life. Thickened liquids are commonly recommended for individuals with dysphagia, as they flow more slowly and reduce the risk of entry into the airway. However, there is limited understanding about how changes in liquid thickness modulate swallowing physiology in individuals with neurodegenerative conditions, and previous reports have shown that increased liquid thickness may contribute to the accumulation of residue in the throat. The purpose of this study is to explore swallowing physiology and function in individuals with neurodegenerative conditions, across five levels of liquid thickness (thin, slightly-thick, mildly-thick, moderately-thick, and extremely-thick), and to identify boundaries of "optimal liquid thickness", which maintain airway safety, without contributing to the accumulation of significant residue. Results from this study will help guide the clinical recommendations for thickened liquids in dysphagia management.
Interventions
- DIAGNOSTIC_TEST Videofluoroscopic Swallowing Examination
- OTHER Tongue Strength Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03192358
The ClinicalTrials.gov registry entry for NCT03192358 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Health Network, Toronto, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Videofluoroscopic Swallowing Examination is the first listed.
NCT03192358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03192358 about?
NCT03192358 is a clinical study titled "Physiological Flow of Liquids Used in Dysphagia Management (Neuro)". For individuals with neurodegenerative conditions, such as Amyotrophic Lateral Sclerosis and Parkinson disease, swallowing impairment (i.e., dysphagia) is a common and serious symptom. Dysphagia places the affected individual at risk for secondary health consequences, including malnutrition and aspi...
What is the current status of trial NCT03192358?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-11-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03192358?
The interventions under investigation include: Videofluoroscopic Swallowing Examination (DIAGNOSTIC_TEST), Tongue Strength Measurement (OTHER).
Who is sponsoring clinical trial NCT03192358?
This trial is sponsored by University Health Network, Toronto, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.